226 related articles for article (PubMed ID: 31191193)
1. Microbiological Screening of Platelet Concentrates in Europe.
Prax M; Bekeredjian-Ding I; Krut O
Transfus Med Hemother; 2019 Apr; 46(2):76-86. PubMed ID: 31191193
[TBL] [Abstract][Full Text] [Related]
2. Pathogen-reduced platelets for the prevention of bleeding.
Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
[TBL] [Abstract][Full Text] [Related]
3. Current debate on pathogen inactivation of platelet concentrates--to use or not to use?
Hervig T; Seghatchian J; Apelseth TO
Transfus Apher Sci; 2010 Dec; 43(3):411-414. PubMed ID: 21075686
[TBL] [Abstract][Full Text] [Related]
4. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
Hitzler WE
Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
[TBL] [Abstract][Full Text] [Related]
5. Improving the bacteriological safety of platelet transfusions.
Blajchman MA; Goldman M; Baeza F
Transfus Med Rev; 2004 Jan; 18(1):11-24. PubMed ID: 14689374
[TBL] [Abstract][Full Text] [Related]
6. Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients.
Klausen SS; Hervig T; Seghatchian J; Reikvam H
Transfus Apher Sci; 2014 Oct; 51(2):97-102. PubMed ID: 25242310
[TBL] [Abstract][Full Text] [Related]
7. Bacterial contamination of platelets for transfusion: strategies for prevention.
Levy JH; Neal MD; Herman JH
Crit Care; 2018 Oct; 22(1):271. PubMed ID: 30367640
[TBL] [Abstract][Full Text] [Related]
8. Bacterial detection of platelets: current problems and possible resolutions.
Blajchman MA; Beckers EA; Dickmeiss E; Lin L; Moore G; Muylle L
Transfus Med Rev; 2005 Oct; 19(4):259-72. PubMed ID: 16214015
[TBL] [Abstract][Full Text] [Related]
9. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety.
Murphy WG; Foley M; Doherty C; Tierney G; Kinsella A; Salami A; Cadden E; Coakley P
Vox Sang; 2008 Jul; 95(1):13-9. PubMed ID: 18393945
[TBL] [Abstract][Full Text] [Related]
10. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes.
Corash L
Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276
[TBL] [Abstract][Full Text] [Related]
11. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine.
Hillyer CD; Josephson CD; Blajchman MA; Vostal JG; Epstein JS; Goodman JL
Hematology Am Soc Hematol Educ Program; 2003; ():575-89. PubMed ID: 14633800
[TBL] [Abstract][Full Text] [Related]
12. Bacterial contamination of platelet concentrates: incidence, significance, and prevention.
Blajchman MA; Goldman M
Semin Hematol; 2001 Oct; 38(4 Suppl 11):20-6. PubMed ID: 11727282
[TBL] [Abstract][Full Text] [Related]
13. Fatal bacterial infections associated with platelet transfusions--United States, 2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Feb; 54(7):168-70. PubMed ID: 15729217
[TBL] [Abstract][Full Text] [Related]
14. Bacterial contamination of platelet components: potential solutions to prevent transfusion-related sepsis.
Corash L
Expert Rev Hematol; 2011 Oct; 4(5):509-25. PubMed ID: 21939419
[TBL] [Abstract][Full Text] [Related]
15. Aerobic Bacterial Contamination In Platelet Concentrates At The Regional Blood Centre, Peshawar.
Ibrahim M; Khan MN; Arif M; Anwar SA; Saba NE; Yousafzai YM
J Ayub Med Coll Abbottabad; 2023; 35(3):447-451. PubMed ID: 38404090
[TBL] [Abstract][Full Text] [Related]
16. 10 Years Experience with Bacterial Screening of Platelet Concentrates in the Netherlands.
de Korte D
Transfus Med Hemother; 2011; 38(4):251-254. PubMed ID: 22016695
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States.
Bell CE; Botteman MF; Gao X; Weissfeld JL; Postma MJ; Pashos CL; Triulzi D; Staginnus U
Clin Ther; 2003 Sep; 25(9):2464-86. PubMed ID: 14604745
[TBL] [Abstract][Full Text] [Related]
18. Economics of pathogen inactivation technology for platelet concentrates in Japan.
Staginnus U; Corash L
Int J Hematol; 2004 Nov; 80(4):317-24. PubMed ID: 15615255
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic methods for platelet bacteria screening: current status and developments.
Störmer M; Vollmer T
Transfus Med Hemother; 2014 Feb; 41(1):19-27. PubMed ID: 24659944
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of bacteriologic screening in platelet concentrates.
te Boekhorst PA; Beckers EA; Vos MC; Vermeij H; van Rhenen DJ
Transfusion; 2005 Apr; 45(4):514-9. PubMed ID: 15819671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
